TP53 and breast carcinoma: They reported numerous high prevalence genes (>5% in the TCGA dataset), including TP53, PIK3CA, and MLL3, that were mutated much more frequently in one race than in the other, implying that these genes may affect the difference in breast cancer mortality rate [12].